Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site (original) (raw)

References

Berlose JP, Convert O, Derossi D, Brunissen A, and Chassaing G . (1996). Eur. J. Biochem., 242, 372–386.
Bottger A, Bottger V, Sparks A, Liu WL, Howard SF, and Lane DP . (1997). Curr. Biol., 7, 860–869.
Brugidou J, Legrand C, Mery J, and Rabie A . (1995). Biochem. Biophys. Res. Commun., 214, 685–693.
Couet J, Li S, Okamoto T, Ikezu T, and Lisanti MP . (1997). J. Biol. Chem., 272, 6525–6533.
De Kroon AIPM, De Gier J, and De Kruijff B . (1993). Lipid–Peptide Interactions in Model Systems-Membrane Insertion and Translocation of Peptides: Protein–Lipid Interactions. Elsevier: Amsterdam.
Book Google Scholar
Delaconstantinos G . (1987). Anticancer Res., 7, 1011–1021.
Derossi D, Chassaing G, and Prochiantz A . (1998). Trends Cell Biol., 8, 84–87.
Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, and Prochiantz A . (1996). J. Biol. Chem., 271, 18188–18193.
Eisenberg D, Weiss RM, and Terwilliger TC . (1984). Proc. Natl. Acad. Sci., 81, 140–144.
Fahraeus R, Fischer P, Krausz E, and Lane DP . (1999). J. Pathol., 187, 138–146.
Fine RL, Chambers TC, and Sachs CW . (1996). Oncologist, 1, 261–268.
Foster BA, Coffey HA, Morin MJ, and Rastinejad F . (1999). Science, 286, 2507–2510.
Garnier J,G. J-F, and Robson B . (1996). Methods in Enzymology. Doolittle, R (ed). Academic Press: New York, pp. 540–553.
Harris CC . (1996). J. Natl. Cancer Inst., 88, 1442–1455.
Kanovsky M, Raffo A, Drew L, Rosal R, Do T, Friedman FK, Rubinstein P, Visser J, Brandt-Rauf PW, Fine R, Michl J, and Pincus MR . (2001). Proc. Natl. Acad. Sci., 98, 12438–12443.
Kim AL, Raffo AJ, Brandt-Rauf PW, Pincus MP, Monaco R, Abarzua P, and Fine RL . (1999). J. Biol. Chem., 274, 34924–34931.
Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, and Pavletich NP . (1996). Science, 274, 948–953.
Levine AJ, Perry ME, Chang A, Silver A, Dihmer D, Wu M, and Welsh D . (1994). Br. J. Cancer, 69, 409–416.
Levine AJ . (1997). Cell, 88, 323–331.
Lofts FJ, Hurst HC, Sternberg MJE, and Gullick WJ . (1993). Oncogene, 8, 2813–2820.
Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, and Lane DP . (2000). Oncogene, 19, 2312–2323.
Momand J, Zambetti GP, Olson DC, George D, and Levine AJ . (1992). Cell, 69, 1237–1245.
Ozbun MA and Butel JS . (1995). Adv. Cancer Res., 66, 71–141.
Perczel A, Park K, and Fasman GD . (1991). Anal Biochem, 4, 669–679
Prives C and Hall PA . (1999). J. Pathol., 187, 112–126.
Prochiantz A . (1999). Ann. N. Y. Acad. Sci., 886, 172–179.
Rousselle C, Clair P, Lefauconnier JM, Kaczorek M, Scherrmann JM, and Temsamani J . (2000). Mol. Pharmacol., 57, 679–686
Schwarze SR and Dowdy SF . (2000). Trends Pharmacol. Sci., 21, 45–48.
Schwarze SR, Hruska KA, and Dowdy SF . (2000). Trends Cell Biol., 10, 290–295.
Segrest JP, De Loof H, Dohlman JG, Brouillette CG, and Anantharamaiah GM . (1990). Proteins, 8, 103–117.
Selivanova G, Ryabchenko L, Jansson E, Iotsova V, and Wiman KG . (1999). Mol. Cell Biol., 19, 3395–3402.
Selivanova G, Iotsova V, Okan I, Fritsche M, Strom M, Groner B, Grafstrom RC, and Wiman KG . (1997). Nat. Med., 3, 632–638.
Sherbert GV . (1989). Exp. Cell Biol., 57, 198–205.
Soussi T . (2000a). Bull. Cancer, 87, 689–690.
Soussi T . (2000b). Ann. N. Y. Acad. Sci., 910, 121–137.
Soussi T, Caron de Fromentel C, and May P . (1990). Oncogene, 5, 945–952.
Spector AA and Burns CD . (1987). Cancer Res., 47, 4529–4537.
Sreerama N and Woody RW (1993). Anal. Biochem., 209, 32–44.
Velculescu VE and El-Deiry WS . (1996). Clin. Chem., 42, 858–868.
Wang JL, Zhang ZJ, Choksi S, Shan S, Lu Z, Croce CM, Alnemri ES, Korngold R, and Huang Z . (2000). Cancer Res., 60, 1498–1502.
Wasylyk C, Salvi R, Argentini M, Dureuil C, Delumeau I, Abecassis J, Debussche L, and Wasylyk B . (1999). Oncogene., 18, 1921–1934.
Yeung TK, Germond C, Chen X, and Wang Z . (1999). Biochem. Biophys. Res. Commun., 263, 398–404.
Zhang R and Wang H . (2000). Curr. Pharmaceut. Des., 6, 393–416.

Download references